These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19643813)

  • 41. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
    Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA
    Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer.
    Kawajiri K; Eguchi H; Nakachi K; Sekiya T; Yamamoto M
    Cancer Res; 1996 Jan; 56(1):72-6. PubMed ID: 8548778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
    Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
    Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients.
    Ryberg D; Hewer A; Phillips DH; Haugen A
    Cancer Res; 1994 Nov; 54(22):5801-3. PubMed ID: 7954403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p53 Mutations in lung cancer associated with residential radon exposure.
    Yngveson A; Williams C; Hjerpe A; Lundeberg J; Söderkvist P; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):433-8. PubMed ID: 10350439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
    Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
    Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smoking-related O4-ethylthymidine formation in human lung tissue and comparisons with bulky DNA adducts.
    Anna L; Kovács K; Gyorffy E; Schoket B; Nair J
    Mutagenesis; 2011 Jul; 26(4):523-7. PubMed ID: 21454326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer.
    Cho S; Kim MJ; Choi YY; Yoo SS; Lee WK; Lee EJ; Jang EJ; Bae EY; Jin G; Jeon HS; Lee SY; Cha SI; Park TI; Kim CH; Park JY
    Lung Cancer; 2011 Jul; 73(1):25-31. PubMed ID: 21129811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis of prognostic value of TP53 gene mutations in non-small cell lung cancer].
    Szymanowska A; Jassem E; Dziadziuszko R; Skrzypski M; Kobierska-Gulida G; Holm K; Borg A; Rzyman W; Limon J; Jassem J
    Pneumonol Alergol Pol; 2005; 73(3):264-9. PubMed ID: 16989164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age-related function of tumor suppressor gene TP53:contribution to cancer risk and progression.
    Cherdyntseva NV; Gervas PA; Litvyakov NV; Stakcheeva MN; Ponomaryeva AA; Dobrodeev AY; Denisov EV; Belyavskaya VA; Choinzonov EL
    Exp Oncol; 2010 Sep; 32(3):205-8. PubMed ID: 21403619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels.
    Kure EH; Ryberg D; Hewer A; Phillips DH; Skaug V; Baera R; Haugen A
    Carcinogenesis; 1996 Oct; 17(10):2201-5. PubMed ID: 8895489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort.
    Scoccianti C; Vesin A; Martel G; Olivier M; Brambilla E; Timsit JF; Tavecchio L; Brambilla C; Field JK; Hainaut P;
    Eur Respir J; 2012 Jul; 40(1):177-84. PubMed ID: 22267755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations.
    Tekpli X; Landvik NE; Skaug V; Gulsvik A; Haugen A; Zienolddiny S
    Int J Cancer; 2013 Apr; 132(8):1811-20. PubMed ID: 23011884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Profile of TP53 gene mutations in sinonasal cancer.
    Holmila R; Bornholdt J; Suitiala T; Cyr D; Dictor M; Steiniche T; Wolff H; Wallin H; Luce D; Husgafvel-Pursiainen K
    Mutat Res; 2010 Apr; 686(1-2):9-14. PubMed ID: 20025891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of TP53 mutations on the prognosis of patients with early stage non-small cell lung cancer may depend on the intratumor heterogeneity of the mutations.
    Lee SY; Jeon HS; Hwangbo Y; Jeong JY; Park JY; Lee EJ; Jin G; Shin KM; Yoo SS; Lee J; Lee EB; Cha SI; Kim CH; Park JY
    Mol Carcinog; 2015 Feb; 54(2):93-101. PubMed ID: 24038464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lifestyle, environmental, and genetic predictors of bulky DNA adducts in a study population nested within a prospective Danish cohort.
    Eriksen KT; Sørensen M; Autrup H; Vogel U; Overvad K; Tjønneland A; Loft S; Raaschou-Nielsen O
    J Toxicol Environ Health A; 2010; 73(9):583-95. PubMed ID: 20391138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bulky DNA adducts as risk indicator of lung cancer in a Danish case-cohort study.
    Bak H; Autrup H; Thomsen BL; Tjønneland A; Overvad K; Vogel U; Raaschou-Nielsen O; Loft S
    Int J Cancer; 2006 Apr; 118(7):1618-22. PubMed ID: 16217769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p53 gene mutations in non-small cell lung cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.
    Zhao Y; Wu D; Xiang X; Zhang B; Zhou N; Hu Y
    Chin Med Sci J; 1999 Sep; 14(3):134-7. PubMed ID: 12903811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of cancer specific mutations in early-stage non-small cell lung cancer using cell-free DNA by targeted sequencing.
    He Y; Zhang X; Wang L; Tian Z; Liu Q; Yao J; Liu Y; Li C; Min L; Shan B
    Int J Oncol; 2016 Dec; 49(6):2351-2358. PubMed ID: 27748796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.